The hypoxic response of tumor cells is largely regulated by HIF-1, as mentioned above; however, in addition to HIF-1, epigenetic modifications such as chromatin condensation have also been thought to play a crucial role in regulating cell cycles and contribute significantly to the therapeutic resistance of hypoxic cancer cells [189]. The gene discussed is HIF1A; the disease is neoplasm.